In regard to Donaldson et al: Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma - A report from the IRSG. IJROBP 2001;51:718-728 [6] (multiple letters)

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 5, 2002, Pages 1579-1580

  Timmerman, Robert D ^a   Mendonca, Marc ^a   Donaldson, Sarah S ^b   Withers, H Rodney ^c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS MALFORMATION; CALCULATION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; LETTER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RHABDOMYOSARCOMA; SAMPLE SIZE;

EID: 0036891107     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0360-3016(02)03015-8     Document Type: Letter

References (3)

1. S.S. Donaldson J. Meza J.C. Breneman Results from the IRS-IV randomized trial of hyperfractionated radiotherapy in children with rhabdomyosarcoma—a report from the IRSG Int J Radiat Oncol Biol Phys 51 2001 718 728
2. D.A. Larson J.C. Flickenger J.S. Loeffler The radiobiology of radiosurgery Int J Radiat Oncol Biol Phys 25 1993 557 561
3. J. Fowler R. Chappell M. Ritter Is the alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031